US FDA Extends UDI Deadlines For Low-Risk Devices

The agency slowed down its effort to require the overwhelming majority of medical devices to adopt Unique Device Identifiers with a new guidance that would in delay full implementation of the UDI system for lower-risk devices.

US FDA is providing some relief for manufacturers of most class I and unclassified devices that would require complying with the its Unique Device Identifier requirements. According to the agency, device-makers will now have an additional two years after new requirements come into effect (this year) before it decides to enforce them.

The agency's UDI regulations technically requires newly manufactured class I and unclassified medical devices to adhere to the agency's UDI labeling, Global UDI Database submission and standard date format requirements...

More from Regulation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.